XYNOMIC PHARMACEUTICALS HOLDINGS, INC.
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 90.27B | ||||||
| 40.12B | ||||||
| 31.75B | ||||||
| 26.6B | ||||||
| 14.41B |
